Cooper Companies
Cooper Companies, officially known as The Cooper Companies, Inc., is a leading global medical device company headquartered in the United States. Founded in 1980, the company has established a strong presence in the eye care and women's health sectors, with significant operations across North America, Europe, and Asia. Specialising in contact lenses and surgical instruments, Cooper Companies is renowned for its innovative products, including the popular CooperVision contact lenses, which prioritise comfort and eye health. The company has achieved notable milestones, such as expanding its product portfolio through strategic acquisitions, solidifying its position as a market leader. With a commitment to enhancing the quality of life through advanced technology, Cooper Companies continues to set industry standards and drive growth in the medical device landscape.
DitchCarbon Score
How does Cooper Companies's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cooper Companies's score of 23 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cooper Companies's reported carbon emissions
In 2023, Cooper Companies reported total carbon emissions of approximately 86,976,000 kg CO2e, comprising 58,490,000 kg CO2e from Scope 1 and 28,486,000 kg CO2e from Scope 2 emissions. This marked a significant increase in emissions compared to previous years, with 2022 emissions at about 83,422,000 kg CO2e, which included 29,716,000 kg CO2e from Scope 1 and 53,706,000 kg CO2e from Scope 2. In 2021, the company achieved a total of approximately 88,958,000 kg CO2e, with Scope 1 emissions at 9,339,000 kg CO2e and Scope 2 emissions at 79,618,000 kg CO2e. The 2020 emissions were notably higher at around 124,378,000 kg CO2e, with Scope 1 contributing 29,104,000 kg CO2e and Scope 2 at 95,274,000 kg CO2e. The trend indicates fluctuations in emissions, with a peak in 2020. Despite these figures, Cooper Companies has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. The company operates within the medical device industry, which is increasingly focusing on sustainability and carbon footprint reduction. As such, Cooper Companies may need to enhance its climate commitments to align with industry standards and stakeholder expectations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 29,747,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 33,442,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cooper Companies is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
